CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED 華潤醫藥集團有限公司
Please note that due to the planned shutdown of Webb-site.com,
the directors, officers and advisers of HK-listed companies will cease to be updated effective 2025-03-31. Appointments
and resignations effective on or before that date will be recorded, as will advisers recorded in annual reports
filed on or before that date. We intend to make a data dump available after processing the final filings.
Regular advisers
Some data are hidden to fit your display. Rotate?
One-time advisers
| Adviser | Role | Added |
| Baker Tilly Hong Kong Limited | Rep Accountant | 2024-07-17 |
| BANK OF CHINA (HONG KONG) LIMITED | Receiving Bank | 2016-10-17 |
| Beijing China Enterprise Appraisals Co., Ltd. | Valuer (1-time) | 2024-07-17 |
| Beijing Pan China Assets Appraisal Co. Limited | Valuer (1-time) | 2024-03-22 |
| CCB INTERNATIONAL CAPITAL LIMITED | Sponsor | 2016-10-17 |
| CHINA INTERNATIONAL CAPITAL CORPORATION HONG KONG SECURITIES LIMITED | Sponsor | 2016-10-17 |
| China Sunrise Capital Limited | IFA (Listing Rules) | 2024-07-12 |
| Ernst & Young (HK) | Rep Accountant | 2020-12-24 |
| FRESHFIELDS | Underwriters' Lawyer (IPO) | 2016-10-17 |
| GOLDMAN SACHS (ASIA) L.L.C. | Sponsor | 2016-10-17 |
| King & Wood Mallesons (PRC) | Underwriters' Lawyer (IPO) | 2016-10-17 |
| KPMG (HK) | Rep Accountant | 2024-03-22 |
| Merrill Lynch Far East Limited | Sponsor | 2016-10-17 |
Copyright & disclaimer, Privacy policy